A heterogeneous enzymatic assay for quantification of Plasmepsin II activity and the evaluation of its inhibitors
- 1 March 2004
- journal article
- Published by Elsevier BV in Journal of Pharmaceutical and Biomedical Analysis
- Vol. 34 (4), 833-840
- https://doi.org/10.1016/s0731-7085(03)00566-1
Abstract
No abstract availableKeywords
This publication has 20 references indexed in Scilit:
- Aspartic proteases of Plasmodium falciparum and other parasitic protozoa as drug targetsTrends in Parasitology, 2001
- Mode of action and mechanisms of resistance for antimalarial drugsPharmacology & Therapeutics, 2001
- Naturally-occurring and recombinant forms of the aspartic proteinases plasmepsins I and II from the human malaria parasite Plasmodium f alciparumFEBS Letters, 1999
- An Overview of Chemotherapeutic Targets for Antimalarial Drug DiscoveryPharmacology & Therapeutics, 1999
- HEMOGLOBIN METABOLISM IN THE MALARIA PARASITEPLASMODIUM FALCIPARUMAnnual Review of Microbiology, 1997
- Biosynthesis and Maturation of the Malaria Aspartic Hemoglobinases Plasmepsins I and IIPublished by Elsevier BV ,1997
- Structure and inhibition of plasmepsin II, a hemoglobin-degrading enzyme from Plasmodium falciparum.Proceedings of the National Academy of Sciences of the United States of America, 1996
- Sequence, expression and modeled structure of an aspartic proteinase from the human malaria parasite Plasmodium falciparumMolecular and Biochemical Parasitology, 1994
- Quinoline-containing antimalarials—mode of action, drug resistance and its reversal an update with unresolved puzzlesBiochemical Pharmacology, 1992
- Plasmodium:resistance to antimalarial drugsAnnales de Parasitologie Humaine et Comparée, 1990